[go: up one dir, main page]

WO2008094493A3 - Compositions contenant de la lactoferrine et du calcium, et leurs procédés d'utilisation - Google Patents

Compositions contenant de la lactoferrine et du calcium, et leurs procédés d'utilisation Download PDF

Info

Publication number
WO2008094493A3
WO2008094493A3 PCT/US2008/001073 US2008001073W WO2008094493A3 WO 2008094493 A3 WO2008094493 A3 WO 2008094493A3 US 2008001073 W US2008001073 W US 2008001073W WO 2008094493 A3 WO2008094493 A3 WO 2008094493A3
Authority
WO
WIPO (PCT)
Prior art keywords
calcium
methods
lactoferrin
compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/001073
Other languages
English (en)
Other versions
WO2008094493A2 (fr
Inventor
David K Yang
Scott Deeter
Juvenal Higiro
Ning Huang
Delia Bethell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Invitria Inc
Original Assignee
Ventria Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventria Bioscience Inc filed Critical Ventria Bioscience Inc
Publication of WO2008094493A2 publication Critical patent/WO2008094493A2/fr
Publication of WO2008094493A3 publication Critical patent/WO2008094493A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

D'une manière générale, la présente invention concerne des compositions contenant de la lactoferrine et du calcium, ainsi que des procédés de fabrication des compositions. Les compositions peuvent également comporter des ingrédients additionnels utiles pour favoriser et/ou maintenir la santé osseuse, et/ou des ingrédients additionnels utiles pour favoriser l'absorption et/ou la biodisponibilité de la lactoferrine et du calcium, tel que la vitamine D. La présente invention concerne des procédés pour favoriser et/ou maintenir la santé osseuse, et le traitement et/ou la prévention de désordres osseux, par l'administration de compositions comportant de la lactoferrine et du calcium.
PCT/US2008/001073 2007-01-26 2008-01-28 Compositions contenant de la lactoferrine et du calcium, et leurs procédés d'utilisation Ceased WO2008094493A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89749007P 2007-01-26 2007-01-26
US60/897,490 2007-01-26

Publications (2)

Publication Number Publication Date
WO2008094493A2 WO2008094493A2 (fr) 2008-08-07
WO2008094493A3 true WO2008094493A3 (fr) 2008-11-20

Family

ID=39674683

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/001073 Ceased WO2008094493A2 (fr) 2007-01-26 2008-01-28 Compositions contenant de la lactoferrine et du calcium, et leurs procédés d'utilisation

Country Status (1)

Country Link
WO (1) WO2008094493A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030191193A1 (en) * 2002-04-03 2003-10-09 Jillian Cornish Lactoferrin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030191193A1 (en) * 2002-04-03 2003-10-09 Jillian Cornish Lactoferrin

Also Published As

Publication number Publication date
WO2008094493A2 (fr) 2008-08-07

Similar Documents

Publication Publication Date Title
TW200612892A (en) Novel compounds
WO2007068894A3 (fr) Nouveaux composes
WO2007064883A3 (fr) Derives substitues de 4-amino-pyrrolotriazine utiles dans le traitement de troubles hyperproliferatifs et de maladies associees a l'angiogenese
TW200519075A (en) Novel compounds
WO2007064931A3 (fr) Derives substitues de 4-amino-pyrrolotriazine utiles dans le traitement de troubles hyperproliferatifs et de maladies associees a l'angiogenese
MXPA05010682A (es) Compuestos novedosos.
WO2005004818A3 (fr) Composes heterocycliques et leur utilisation comme agents anticancereux
WO2006037024A3 (fr) Sels de decitabine
WO2007109279A3 (fr) Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation
WO2006124748A3 (fr) Composes polycycliques et procedes pour les utiliser
WO2006096434A3 (fr) Compositions pharmaceutiques permettant de traiter et/ou de prevenir les troubles de l'anxiete
TW200630336A (en) Novel compounds
WO2008148873A3 (fr) Compositions d'hydroxyproline et leurs utilisations
WO2010130830A3 (fr) Séquences d'acides aminés dirigées contre la sclérostine et polypeptides comprenant ces dernières pour le traitement de maladies et de pathologies des os
TW200745003A (en) Novel compounds
WO2007016538A3 (fr) Preparation et utilisation de derives aminoacides biphenyle pour traiter l'obesite
MX2009004714A (es) Derivados de pirazol fusionado 3-aminocarbonilo sustituidos como moduladores de proteina cinasa.
MY143795A (en) Tetrahydropyridoindole derivatives
TW200621690A (en) Novel compounds
WO2007052023A3 (fr) Composes
WO2005086656A3 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
WO2007076085A3 (fr) Pyrimidones et thiopyrimidones fusionnees et leurs utilisations
WO2008061108A3 (fr) Dérivés de phtalazine
WO2006123031A3 (fr) Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou l’un de ses derives a l'etat solubilise
GB0611907D0 (en) Compounds

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08724854

Country of ref document: EP

Kind code of ref document: A2